Unknown PHASE4 INTERVENTIONAL 2-arm NCT00912457

Donepezil Treatment for Sleep Apnea Patients (doneapnea)

Donepezil Treatment for Sleep Apnea Patients: A Double Blind Placebo-Controlled Study

Sponsor: Associacao Fundo de Incentivo a Psicofarmcologia

Updated 5 times since 2017 Last updated: Jun 2, 2009 Started: Mar 31, 2007 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Obstructive Sleep Apnea, this trial is ongoing. The trial is conducted by Associacao Fundo de Incentivo a Psicofarmcologia and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Associacao Fundo de Incentivo a Psicofarmcologia
Fundação de Amparo à Pesquisa do Estado de São Paulo

Data source: Associacao Fundo de Incentivo a Psicofarmcologia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil